Head and neck cancer: how can a clinical oncologist help?

Written in association with: Professor Chris Nutting
Published:
Edited by: Laura Burgess

If you have been diagnosed with head and neck cancer, you will be referred to see an oncologist and his team who will devise a treatment plan that is determined by the type and stage of the tumour. We asked one of our top clinical oncologists, Professor Chris Nutting, as to what can be expected exactly.

Two hands of different people holding each other in comfort

What are the commonest locations for head and neck cancer?

The commonest tumour sites are in the tongue or mouth and in the swallowing tube (pharynx) or voicebox (larynx). Only tumours of the mouth and tonsil cancers are visible by direct examination.
 

How do you determine which treatment option is right for head and neck cancer?

Following biopsy to identify the histological type of tumour and staging to determine the extent of the tumour at diagnosis, usually, the main options are between surgical resection or chemo-radiotherapy.

Surgical resection is preferred in patients where the tumour can be easily removed with little cosmetic or functional complications and chemo-radiation is reserved for other patients.
 

How does a clinical oncologist treat head and neck cancer?

The clinical oncologist is primarily responsible for radiation treatment and chemotherapy. They also participate in the multidisciplinary team with staging, selection of appropriate treatment options and supervision of the treatment itself. Management should be within specialist centres supported by clinical nurse specialists, dieticians, speech therapists and others.
 

Can some head and neck cancers be cured during early-stages?

The cure rates can be in excess of 90% for some cases. but if the cancer is locally advanced or has spread to lymph nodes in the neck then the cure rate ranges from 40-80%.


You can book an appointment with Professor Nutting via his Top Doctor’s profile here.

By Professor Chris Nutting
Clinical oncology

Professor Christopher Nutting is a prominent consultant clinical oncologist in London whose areas of expertise include head and neck cancer, thyroid cancer, lung cancer and CyberKnife. He is a specialist in radiotherapy and chemotherapy with a particular interest in reducing the side effects of treatment by using highly focussed radiotherapy. 

After graduating from the University of London Professor Nutting went on to take a number of important posts and has become a highly experienced and an extremely well-respected oncologist in London. 

Besides his medical experience, Professor Nutting has impressive teaching credentials, having been appointed Professor in clinical oncology at The Institute of Cancer Research. 

Professor Nutting is keen to offer the best and most up-to-date care for his patients and is at the forefront of his field when it comes to radiotherapy techniques. He is actively involved in research and has contributed to countless peer-reviewed publications. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.